This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/pharmgkb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/kegg-compound/
n21http://linked.opendata.cz/resource/drugbank/company/
n18http://linked.opendata.cz/resource/mesh/concept/
n14http://linked.opendata.cz/resource/drugbank/dosage/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/iuphar/
n23http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/guide-to-pharmacology/
n15http://linked.opendata.cz/resource/drugbank/patent/
n20http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03128/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03128
rdf:type
n3:Drug
n3:description
A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. [PubChem]
n3:dosage
n14:271B51B9-363D-11E5-9242-09173F13E4C5
n3:group
experimental
owl:sameAs
n20:DB03128 n23:DB03128
dcterms:title
Acetylcholine
adms:identifier
n6:15355 n7:DB03128 n8:187 n9:46504484 n10:C01996 n11:ACH n12:294 n13:294 n16:PA448031
n3:packager
n21:271B51B8-363D-11E5-9242-09173F13E4C5 n21:271B51B7-363D-11E5-9242-09173F13E4C5
n3:patent
n15:6261546
n3:synonym
Acetylcholine Chloride
n3:synthesisReference
Masao Tanihara, Hideaki Yamada, Toshihide Nakashima, Yoshiaki Omura, Koichi Takakura, "Human IgG.sub.1 monoclonal antibody specific for the nicotinic acetylcholine receptor and hybridoma producing the antibody." U.S. Patent US5192684, issued December, 1984.
n17:hasConcept
n18:M0000165
n3:IUPAC-Name
n4:271B51BE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B51C4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B51C3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B51C0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B51C1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B51C2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B51BC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B51BA-363D-11E5-9242-09173F13E4C5 n4:271B51BD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B51BB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B51CA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B51CB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B51C5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B51C6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B51C8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B51C7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B51C9-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
51-84-3
n3:category
n3:Bioavailability
n4:271B51CF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B51D1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B51D2-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B51CE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B51CD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B51D0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B51BF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B51CC-363D-11E5-9242-09173F13E4C5